A phase II trial of guselkumab for Crohn's disease. | Nat Rev Gastroenterol Hepatol;19(4): 216, 2022 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

A phase II trial of guselkumab for Crohn's disease.

Hindson, Jordan.

Hindson J; Nature Reviews Gastroenterology & Hepatology, . nrgasthep@nature.com.

Nat Rev Gastroenterol Hepatol ; 19(4): 216, 2022 04.

Article in English | MEDLINE | ID: covidwho-1783992

Subject(s)

Antibodies, Monoclonal, Humanized; Crohn Disease; Antibodies, Monoclonal, Humanized/therapeutic use; Crohn Disease/drug therapy; Humans

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Crohn Disease / Antibodies, Monoclonal, Humanized Type of study: Randomized controlled trials Limits: Humans Language: English Journal: Nat Rev Gastroenterol Hepatol Journal subject: Gastroenterology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Crohn Disease / Antibodies, Monoclonal, Humanized Type of study: Randomized controlled trials Limits: Humans Language: English Journal: Nat Rev Gastroenterol Hepatol Journal subject: Gastroenterology Year: 2022 Document Type: Article